ID   HAOX2_HUMAN             Reviewed;         351 AA.
AC   Q9NYQ3; Q2TU86; Q5QP00; Q9UJS6;
DT   21-FEB-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   15-MAR-2017, entry version 135.
DE   RecName: Full=Hydroxyacid oxidase 2;
DE            Short=HAOX2;
DE            EC=1.1.3.15;
DE   AltName: Full=(S)-2-hydroxy-acid oxidase, peroxisomal;
DE   AltName: Full=Cell growth-inhibiting gene 16 protein;
DE   AltName: Full=Long chain alpha-hydroxy acid oxidase;
DE   AltName: Full=Long-chain L-2-hydroxy acid oxidase;
GN   Name=HAO2; Synonyms=HAOX2; ORFNames=GIG16;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=10777549; DOI=10.1074/jbc.275.17.12590;
RA   Jones J.M., Morrell J.C., Gould S.J.;
RT   "Identification and characterization of HAOX1, HAOX2, and HAOX3, three
RT   human peroxisomal 2-hydroxy acid oxidases.";
RL   J. Biol. Chem. 275:12590-12597(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Spielbauer B., Conzelmann E.;
RT   "Human long-chain L-2-hydroxy acid oxidase.";
RL   Submitted (NOV-1999) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Kim J.W.;
RT   "Identification of a human cell growth inhibiting gene.";
RL   Submitted (DEC-2003) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Kidney;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Kidney;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-178, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: Catalyzes the oxidation of L-alpha-hydroxy acids as well
CC       as, more slowly, that of L-alpha-amino acids.
CC   -!- CATALYTIC ACTIVITY: (S)-2-hydroxy acid + O(2) = 2-oxo acid +
CC       H(2)O(2).
CC   -!- COFACTOR:
CC       Name=FMN; Xref=ChEBI:CHEBI:58210;
CC   -!- SUBUNIT: Homotetramer or homooctamer. {ECO:0000250}.
CC   -!- INTERACTION:
CC       Q9UDX3:SEC14L4; NbExp=4; IntAct=EBI-8803200, EBI-10320311;
CC   -!- SUBCELLULAR LOCATION: Peroxisome.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9NYQ3-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9NYQ3-2; Sequence=VSP_055095;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Liver and kidney.
CC   -!- SIMILARITY: Belongs to the FMN-dependent alpha-hydroxy acid
CC       dehydrogenase family. {ECO:0000255|PROSITE-ProRule:PRU00683}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF231917; AAF40200.1; -; mRNA.
DR   EMBL; AF203975; AAF14000.1; -; mRNA.
DR   EMBL; AY513277; AAT08030.1; -; mRNA.
DR   EMBL; AK298289; BAG60549.1; -; mRNA.
DR   EMBL; AL139346; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL359553; CAC19798.1; -; Genomic_DNA.
DR   EMBL; CH471122; EAW56698.1; -; Genomic_DNA.
DR   EMBL; CH471122; EAW56699.1; -; Genomic_DNA.
DR   EMBL; BC020863; AAH20863.1; -; mRNA.
DR   CCDS; CCDS76196.1; -. [Q9NYQ3-2]
DR   CCDS; CCDS901.1; -. [Q9NYQ3-1]
DR   RefSeq; NP_001005783.2; NM_001005783.2. [Q9NYQ3-2]
DR   RefSeq; NP_057611.1; NM_016527.3. [Q9NYQ3-1]
DR   UniGene; Hs.659767; -.
DR   ProteinModelPortal; Q9NYQ3; -.
DR   SMR; Q9NYQ3; -.
DR   BioGrid; 119356; 25.
DR   IntAct; Q9NYQ3; 2.
DR   STRING; 9606.ENSP00000316339; -.
DR   BindingDB; Q9NYQ3; -.
DR   ChEMBL; CHEMBL2169732; -.
DR   DrugBank; DB03247; Riboflavin Monophosphate.
DR   iPTMnet; Q9NYQ3; -.
DR   PhosphoSitePlus; Q9NYQ3; -.
DR   BioMuta; HAO2; -.
DR   DMDM; 13124287; -.
DR   EPD; Q9NYQ3; -.
DR   PaxDb; Q9NYQ3; -.
DR   PeptideAtlas; Q9NYQ3; -.
DR   PRIDE; Q9NYQ3; -.
DR   DNASU; 51179; -.
DR   Ensembl; ENST00000325945; ENSP00000316339; ENSG00000116882. [Q9NYQ3-1]
DR   Ensembl; ENST00000361035; ENSP00000354314; ENSG00000116882. [Q9NYQ3-2]
DR   Ensembl; ENST00000622548; ENSP00000483507; ENSG00000116882. [Q9NYQ3-1]
DR   GeneID; 51179; -.
DR   KEGG; hsa:51179; -.
DR   UCSC; uc001ehq.1; human. [Q9NYQ3-1]
DR   CTD; 51179; -.
DR   DisGeNET; 51179; -.
DR   GeneCards; HAO2; -.
DR   HGNC; HGNC:4810; HAO2.
DR   MIM; 605176; gene.
DR   neXtProt; NX_Q9NYQ3; -.
DR   OpenTargets; ENSG00000116882; -.
DR   PharmGKB; PA29186; -.
DR   eggNOG; KOG0538; Eukaryota.
DR   eggNOG; COG1304; LUCA.
DR   GeneTree; ENSGT00390000018717; -.
DR   HOGENOM; HOG000217463; -.
DR   HOVERGEN; HBG051881; -.
DR   InParanoid; Q9NYQ3; -.
DR   KO; K11517; -.
DR   OMA; WNDLSWF; -.
DR   OrthoDB; EOG091G0ADA; -.
DR   PhylomeDB; Q9NYQ3; -.
DR   TreeFam; TF313363; -.
DR   Reactome; R-HSA-390918; Peroxisomal lipid metabolism.
DR   ChiTaRS; HAO2; human.
DR   GenomeRNAi; 51179; -.
DR   PRO; PR:Q9NYQ3; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000116882; -.
DR   CleanEx; HS_HAO2; -.
DR   ExpressionAtlas; Q9NYQ3; baseline and differential.
DR   Genevisible; Q9NYQ3; HS.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; IEA:Ensembl.
DR   GO; GO:0005782; C:peroxisomal matrix; TAS:Reactome.
DR   GO; GO:0005777; C:peroxisome; IDA:UniProtKB.
DR   GO; GO:0003973; F:(S)-2-hydroxy-acid oxidase activity; IDA:UniProtKB.
DR   GO; GO:0010181; F:FMN binding; IEA:InterPro.
DR   GO; GO:0052853; F:long-chain-(S)-2-hydroxy-long-chain-acid oxidase activity; IDA:UniProtKB.
DR   GO; GO:0052854; F:medium-chain-(S)-2-hydroxy-acid oxidase activity; IEA:UniProtKB-EC.
DR   GO; GO:0005102; F:receptor binding; IPI:UniProtKB.
DR   GO; GO:0052852; F:very-long-chain-(S)-2-hydroxy-acid oxidase activity; IEA:UniProtKB-EC.
DR   GO; GO:0044255; P:cellular lipid metabolic process; TAS:Reactome.
DR   GO; GO:0019395; P:fatty acid oxidation; IDA:UniProtKB.
DR   Gene3D; 3.20.20.70; -; 1.
DR   InterPro; IPR013785; Aldolase_TIM.
DR   InterPro; IPR012133; Alpha-hydoxy_acid_DH_FMN.
DR   InterPro; IPR000262; FMN-dep_DH.
DR   InterPro; IPR008259; FMN_hydac_DH_AS.
DR   Pfam; PF01070; FMN_dh; 1.
DR   PIRSF; PIRSF000138; Al-hdrx_acd_dh; 1.
DR   PROSITE; PS00557; FMN_HYDROXY_ACID_DH_1; 1.
DR   PROSITE; PS51349; FMN_HYDROXY_ACID_DH_2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Flavoprotein; FMN;
KW   Oxidoreductase; Peroxisome; Phosphoprotein; Polymorphism;
KW   Reference proteome.
FT   INIT_MET      1      1       Removed. {ECO:0000250|UniProtKB:Q07523}.
FT   CHAIN         2    351       Hydroxyacid oxidase 2.
FT                                /FTId=PRO_0000206320.
FT   DOMAIN        2    351       FMN hydroxy acid dehydrogenase.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00683}.
FT   NP_BIND     277    301       FMN. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00683}.
FT   MOTIF       349    351       Microbody targeting signal.
FT                                {ECO:0000255}.
FT   ACT_SITE    246    246       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00683}.
FT   BINDING     106    106       FMN. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00683}.
FT   BINDING     128    128       FMN. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00683}.
FT   BINDING     130    130       Substrate. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00683}.
FT   BINDING     156    156       FMN. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00683}.
FT   BINDING     165    165       Substrate. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00683}.
FT   BINDING     222    222       FMN. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00683}.
FT   BINDING     249    249       Substrate. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00683}.
FT   BINDING     301    301       FMN. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00683}.
FT   MOD_RES     178    178       Phosphothreonine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   VAR_SEQ       1      1       M -> MEDKMWSECEGPEM (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_055095.
FT   VARIANT      15     15       E -> K (in dbSNP:rs34638261).
FT                                /FTId=VAR_049087.
FT   VARIANT     221    221       L -> M (in dbSNP:rs6661625).
FT                                /FTId=VAR_049088.
FT   CONFLICT     80     80       F -> Y (in Ref. 2; AAF14000).
FT                                {ECO:0000305}.
FT   CONFLICT    292    294       LGA -> HED (in Ref. 2; AAF14000).
FT                                {ECO:0000305}.
SQ   SEQUENCE   351 AA;  38839 MW;  7330DE44E282947D CRC64;
     MSLVCLTDFQ AHAREQLSKS TRDFIEGGAD DSITRDDNIA AFKRIRLRPR YLRDVSEVDT
     RTTIQGEEIS APICIAPTGF HCLVWPDGEM STARAAQAAG ICYITSTFAS CSLEDIVIAA
     PEGLRWFQLY VHPDLQLNKQ LIQRVESLGF KALVITLDTP VCGNRRHDIR NQLRRNLTLT
     DLQSPKKGNA IPYFQMTPIS TSLCWNDLSW FQSITRLPII LKGILTKEDA ELAVKHNVQG
     IIVSNHGGRQ LDEVLASIDA LTEVVAAVKG KIEVYLDGGV RTGNDVLKAL ALGAKCIFLG
     RPILWGLACK GEHGVKEVLN ILTNEFHTSM ALTGCRSVAE INRNLVQFSR L
//
